Is Brexit Really Top of European Pharma’s New Year To-Do List?

The year ended, for European pharma, as it had begun with deep anxieties that the industry's operations would be seriously jeopardized by the widening fissure of the English Channel. Things are still not much clearer, even now, about the likely consequences of ripping one of the largest aOriginal Article